APA (7th ed.) Citation

Tuffs, C., Dupovac, M., Richter, K., Holten, S., Schaschinger, T., Marg, O., . . . Strowitzki, M. (2025). Genetic loss of HIF-prolyl-hydroxylase 1, but not pharmacological inhibition, mitigates hepatic fibrosis. The American journal of pathology, 195(3), . https://doi.org/10.1016/j.ajpath.2024.10.018

Chicago Style (17th ed.) Citation

Tuffs, Christopher, et al. "Genetic Loss of HIF-prolyl-hydroxylase 1, but Not Pharmacological Inhibition, Mitigates Hepatic Fibrosis." The American Journal of Pathology 195, no. 3 (2025). https://doi.org/10.1016/j.ajpath.2024.10.018.

MLA (9th ed.) Citation

Tuffs, Christopher, et al. "Genetic Loss of HIF-prolyl-hydroxylase 1, but Not Pharmacological Inhibition, Mitigates Hepatic Fibrosis." The American Journal of Pathology, vol. 195, no. 3, 2025, https://doi.org/10.1016/j.ajpath.2024.10.018.